Cancer
Conditions
Interventions
None listed
Sponsors
Jichi Medical University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Studies or case reports involving MEITL, type II enteropathy-associated T-cell lymphoma (type II EATL), or intestinal T-cell lymphomas considered compatible with these entities. 2. Reports describing autologous or allogeneic hematopoietic stem cell transplantation. 3. Case reports, case series, retrospective studies, and prospective studies will be eligible. 4. If a study includes other diseases, only reports in which data specific to MEITL/type II EATL can be extracted will be included. 5. No restrictions will be applied with respect to race, country of origin, publication date, or language.
Exclusion criteria
Exclusion criteria: 1. Duplicate publications 2. Conference abstracts only 3. Reports exclusively involving classical EATL/type I EATL 4. Reports with insufficient pathological or clinical information to support compatibility with contemporary MEITL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Descriptive synthesis of post-transplant outcomes, including overall survival, relapse, and non-relapse mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Clinicopathological characteristics at diagnosis and at transplantation 2. Disease status before transplantation (CR/PR/SD/PD or non-CR) 3. Clinical context, indications, and treatment course of autologous and allogeneic transplantation 4. Incidence of acute and chronic graft-versus-host disease 5. Pathology-informed reassessment according to contemporary MEITL diagnostic criteria (definite / probable / atypical / uncertain) | — |
Countries
Japan
Contacts
Public ContactRyutaro Tominaga
Jichi Medical University Hospital Division of Hematology
Outcome results
None listed